XML 21 R24.htm IDEA: XBRL DOCUMENT

18. RESEARCH AND DEVELOPMENT EXPENSES	6 Months Ended
Jun. 30, 2013
Notes to Financial Statements
18. RESEARCH AND DEVELOPMENT EXPENSES	NOTE 18 – RESEARCH AND DEVELOPMENT EXPENSES The total research and development expenses recognized in the income statements during the three-month and six-month periods ended June 30, 2013 were $54,480 and $72,182, respectively, of which the consumption of bromine produced by the Company amounted to $12,461 and $18,582, respectively. The total research and development expenses recognized in the income statements during the three-month and six-month periods ended June 30, 2012 were $62,526 and $105,324, respectively, of which the consumption of bromine produced by the Company amounted to $13,268 and $24,008, respectively.

18. RESEARCH AND DEVELOPMENT EXPENSES

6 Months Ended

Jun. 30, 2013

NOTE 18 – RESEARCH AND DEVELOPMENT EXPENSES

The total research and development expenses recognized in the income statements during the three-month and six-month periods ended June 30, 2013 were $54,480 and $72,182, respectively, of which the consumption of bromine produced by the Company amounted to $12,461 and $18,582, respectively. The total research and development expenses recognized in the income statements during the three-month and six-month periods ended June 30, 2012 were $62,526 and $105,324, respectively, of which the consumption of bromine produced by the Company amounted to $13,268 and $24,008, respectively.